Average Co-Inventor Count = 7.43
ph-index = 3
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Chdi Foundation, Inc. (10 from 53 patents)
2. Ucb Pharma, S.a. (5 from 179 patents)
3. Astrazeneca Ab (3 from 1,500 patents)
4. Eolas Therapeutics, Inc. (2 from 7 patents)
18 patents:
1. 11434236 - Halo-substituted piperidines as orexin receptor modulators
2. 10894789 - Halo-substituted piperidines as orexin receptor modulators
3. 10457675 - Histone deacetylase inhibitors and compositions and methods of use thereof
4. 10105363 - Histone deacetylase inhibitors and compositions and methods of use thereof
5. 10106535 - Histone deacetylase inhibitors and compositions and methods of use thereof
6. 10065948 - Histone deacetylase inhibitors and compositions and methods of use thereof
7. 10053453 - Compounds and their use as BACE inhibitors
8. 9855267 - Histone deacetylase inhibitors and compositions and methods of use thereof
9. 9783488 - Histone deacetylase inhibitors and compositions and methods of use thereof
10. 9765054 - Histone deacetylase inhibitors and compositions and methods of use thereof
11. 9617259 - Histone deacetylase inhibitors and compositions and methods of use thereof
12. 9562021 - Histone deacetylase inhibitors and compositions and methods of use thereof
13. 9505736 - Histone deacetylase inhibitors and compositions and methods of use thereof
14. 8957090 - Fused bicyclic pyridine and pyrazine derivatives as kinase inhibitors
15. 8785628 - Triazine derivatives as kinase inhibitors